Charles River Laboratories
560 hedge funds and large institutions have $13.6B invested in Charles River Laboratories in 2021 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 199 increasing their positions, 211 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.57% more ownership
Funds ownership: 94.16% → 94.73% (+0.57%)
6% less repeat investments, than reductions
Existing positions increased: 199 | Existing positions reduced: 211
21% less call options, than puts
Call options by funds: $52.6M | Put options by funds: $66.8M
Holders
560
Holding in Top 10
17
Calls
$52.6M
Puts
$66.8M
Top Buyers
1 | +$250M | |
2 | +$144M | |
3 | +$130M | |
4 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$65.1M |
5 |
BlackRock
New York
|
+$64.2M |
Top Sellers
1 | -$86.7M | |
2 | -$73.7M | |
3 | -$70M | |
4 |
TCM
TimesSquare Capital Management
New York
|
-$62.4M |
5 |
EIP
Epoch Investment Partners
New York
|
-$62.1M |